Description

This advanced mitochondrial peptide formulation combines SS-31 (Elamipretide) and MOTS-c into a unified bioenergetic and metabolic optimization blend designed for research involving mitochondrial resilience, cellular energy production, metabolic regulation, and healthy aging pathways.

SS-31 is a mitochondria-targeting tetrapeptide studied for its ability to stabilize the inner mitochondrial membrane through selective cardiolipin interaction, supporting electron transport chain efficiency and ATP production under oxidative stress conditions. MOTS-c is a mitochondria-derived metabolic peptide encoded by mitochondrial DNA and investigated for its role in adaptive energy regulation, AMPK activation, glucose metabolism, and mitochondrial biogenesis.

Together, this blend is positioned within experimental frameworks examining synergistic support of mitochondrial integrity, oxidative phosphorylation efficiency, cellular stress resistance, and metabolic flexibility. Rather than acting through stimulatory pathways alone, the peptide complex is studied for its potential role in optimizing endogenous energy systems, preserving mitochondrial function under stress, and supporting long-term cellular resilience.

Research domains include mitochondrial biology, metabolic dysfunction, exercise physiology, oxidative stress regulation, cardiometabolic performance, cellular aging, and longevity-associated signaling pathways.

Our formulation is provided in a stabilized pre-mixed injection pen for SubQ administration. Subcutaneous delivery supports consistent systemic exposure and reliable peptide absorption in research protocols. Each unit is freshly prepared to preserve peptide integrity and ensure standardized dosing. This format eliminates multi-step reconstitution and simplifies laboratory handling. The product is formulated strictly for research use only.

Clinical Status

Human RCT ✔ | Observational ✔ | Animal ✔ | In vitro ✔

Primarily studied in mitochondrial, metabolic, and age-related research settings, with expanding human clinical investigation.

Mechanism of Action

This peptide blend is studied for its combined influence on mitochondrial membrane stability, cellular energy sensing, and adaptive metabolic signaling pathways. SS-31 selectively targets cardiolipin within the inner mitochondrial membrane, supporting electron transport chain efficiency and ATP synthesis while reducing mitochondrial reactive oxygen species generation. MOTS-c acts as a mitochondrial-derived metabolic regulator that activates AMPK and SIRT1 signaling pathways, promoting glucose utilization, fatty acid oxidation, and mitochondrial biogenesis. Together, these mechanisms may support improved bioenergetic efficiency, oxidative stress resistance, and metabolic adaptability in experimental systems.

Benefits

Supports Mitochondrial Membrane Stability And Energy Production

SS-31 has been studied for its selective interaction with cardiolipin in the inner mitochondrial membrane, contributing to stabilization of mitochondrial cristae structure and respiratory chain efficiency. Combined with MOTS-c-mediated metabolic regulation, the blend is positioned within research exploring optimized ATP synthesis and sustained cellular energy availability under stress conditions.

Activates AMPK And Adaptive Metabolic Signaling

MOTS-c is extensively studied for activation of AMP-activated protein kinase (AMPK), a central regulator of cellular energy homeostasis. Through this mechanism, the peptide supports glucose uptake, fatty acid oxidation, and metabolic flexibility. The addition of SS-31 introduces mitochondrial membrane stabilization mechanisms that may complement adaptive energy signaling pathways in experimental metabolic models.

Enhances Oxidative Phosphorylation Efficiency

Research involving SS-31 demonstrates stabilization of electron transport chain supercomplexes and improved mitochondrial respiration dynamics. MOTS-c simultaneously promotes mitochondrial biogenesis and oxidative metabolism through SIRT1 and PGC-1α activation. Together, the blend is studied for coordinated enhancement of oxidative phosphorylation efficiency and mitochondrial performance.

Supports Cellular Resilience Against Oxidative Stress

Mitochondrial dysfunction is closely associated with excessive reactive oxygen species production and cellular damage. SS-31 has been investigated for reducing mitochondrial ROS generation and preserving membrane potential under oxidative challenge. MOTS-c further contributes through regulation of antioxidant response pathways including NRF2 and FOXO3a signaling, positioning the blend within integrated oxidative stress research frameworks.

Improves Metabolic Flexibility And Glucose Utilization

MOTS-c research demonstrates improved insulin sensitivity and enhanced GLUT4-mediated glucose transport in both preclinical and early human studies. Experimental models suggest improved substrate utilization and metabolic efficiency during energetic demand. Combined mitochondrial support from SS-31 may further enhance energy conversion efficiency and metabolic resilience.

Examined In Longevity And Healthy Aging Research

Both peptides are studied extensively in aging-related experimental systems. MOTS-c expression has been observed to decline with age, while SS-31 has demonstrated protective effects against mitochondrial deterioration associated with aging processes. Together, the blend is positioned within longevity research examining preservation of mitochondrial integrity, metabolic stability, and cellular recovery capacity over time.

Supports Exercise Physiology And Muscle Bioenergetics

MOTS-c has demonstrated increased exercise endurance and improved skeletal muscle metabolism in experimental performance models. SS-31 research indicates enhanced mitochondrial respiratory capacity and muscle energy dynamics under physical stress conditions. This complementary activity supports investigation into athletic performance, recovery physiology, and muscular energy optimization.

Modulates Inflammatory And Cellular Stress Pathways

Experimental studies involving MOTS-c demonstrate regulation of inflammatory cytokines including IL-6, TNF-α, and CRP. SS-31 research further supports preservation of mitochondrial function during inflammatory and oxidative stress states. Together, these mechanisms position the blend within research exploring interactions between mitochondrial integrity, inflammation, and systemic metabolic balance.

Supports Neuroprotective And Cognitive Energy Research

Mitochondrial function plays a central role in neural energy metabolism and cognitive resilience. Emerging studies suggest MOTS-c may protect neural tissues from oxidative stress, while SS-31 has been evaluated in mitochondrial dysfunction models involving neuronal energy impairment. The blend is therefore studied in experimental systems examining neuroenergetics and cellular protection pathways.

Distinct Regulatory Profile Focused On Cellular Optimization

Unlike stimulant-based energy compounds that rely on acute nervous system activation, the SS-31 + MOTS-c blend is investigated as a mitochondrial optimization system targeting endogenous cellular energy pathways. Research focuses on improved bioenergetic efficiency, adaptive metabolic regulation, oxidative resilience, and long-term mitochondrial health rather than transient stimulation.

Integrated Mitochondrial–Metabolic–Longevity Research Framework

Cellular energy production, metabolic flexibility, oxidative stress balance, and aging biology are deeply interconnected systems centered around mitochondrial function. The SS-31 + MOTS-c blend is studied within integrated research frameworks examining how optimization of mitochondrial dynamics may influence long-term cellular resilience, physical performance, metabolic stability, and healthy aging processes.